Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A06779 | 32749738 | Int J Clin Pract | Diagnostic performance of fibroscan and computed tomography in 322 normal alanine aminotransferase non-obese non-alcoholic fatty liver disease patients diagnosed by ultrasound. | 2020 | Details |
| A06780 | 32748703 | Exp Lung Res | Quantitative analysis of the global proteome in lung from mice with blast injury. | 2020 | Details |
| A06781 | 32748581 | J Zhejiang Univ Sci B | New observations on the effect of camellia oil on fatty liver disease in rats. | 2021 | Details |
| A06782 | 32748075 | J Med Ultrason (2001) | Advances in ultrasound elastography for nonalcoholic fatty liver disease. | 2020 | Details |
| A06783 | 32747897 | Rom J Morphol Embryol | MR spectroscopy of the liver - a reliable non-invasive alternative for evaluating non-alcoholic fatty liver disease. | 2020 | Details |
| A06784 | 32747349 | BMJ Open | Prevalence trends in non-alcoholic fatty liver disease at the global, regional and national levels, 1990-2017: a population-based observational study. | 2020 | Details |
| A06785 | 32746850 | Cell Commun Signal | The crosstalk: exosomes and lipid metabolism. | 2020 | Details |
| A06786 | 32746645 | Expert Rev Gastroenterol Hepatol | Clinical heterogeneity in patients with non-alcoholic fatty liver disease-associated hepatocellular carcinoma. | 2020 | Details |
| A06787 | 32745698 | Diabetes Res Clin Pract | Screening strategies for nonalcoholic fatty liver disease in type 2 diabetes: Insights from NHANES 2005-2016. | 2020 | Details |
| A06788 | 32745632 | Ann Hepatol | Increased serum selenium levels are associated with reduced risk of advanced liver fibrosis and all-cause mortality in NAFLD patients: National Health and Nutrition Examination Survey (NHANES) III. | 2020 | Details |
| A06789 | 32745630 | Ann Hepatol | Accuracy of non-invasive methods/models for predicting esophageal varices in patients with compensated advanced chronic liver disease secondary to nonalcoholic fatty liver disease. | 2020 | Details |
| A06790 | 32745314 | Liver Int | LncRNA NEAT1: Shedding light on mechanisms and opportunities in liver diseases. | 2020 | Details |
| A06791 | 32744348 | J Food Biochem | Biochemical and histopathological assessment of liver in a rat model of metabolic syndrome induced by high-carbohydrate high-fat diet. | 2020 | Details |
| A06792 | 32744096 | Am J Physiol Endocrinol Metab | Neurodegeneration in juvenile Iberian pigs with diet-induced nonalcoholic fatty liver disease. | 2020 | Details |
| A06793 | 32743224 | ACS Omega | Glycerol-3-phosphate Acyltransferase1 Is a Model-Agnostic Node in Nonalcoholic Fatty Liver Disease: Implications for Drug Development and Precision Medicine. | 2020 | Details |
| A06794 | 32742574 | World J Hepatol | Non-alcoholic fatty liver disease is not independent risk factor for cardiovascular disease event: A cohort study. | 2020 | Details |
| A06795 | 32742358 | Exp Ther Med | Pathophysiology of hepatic Na+/H+ exchange (Review). | 2020 | Details |
| A06796 | 32742180 | Saudi J Biol Sci | The effect of hydroalcoholic Berberis integerrima fruits extract on the lipid profile, antioxidant parameters and liver and kidney function tests in patients with nonalcoholic fatty liver disease. | 2020 | Details |
| A06797 | 32742127 | World J Gastroenterol | Monoacylglycerol lipase reprograms lipid precursors signaling in liver disease. | 2020 | Details |
| A06798 | 32742124 | World J Gastroenterol | Management of nonalcoholic fatty liver disease in the Middle East. | 2020 | Details |
| A06801 | 32740097 | J Clin Gastroenterol | Renal Failure is Associated With Increased Mortality and Hospital Utilization in Patients Admitted With Nonalcoholic Steatohepatitis. | 2021 | Details |
| A06802 | 32739658 | Nutrition | Chronic ingestion of Primex-Z, compared with other common fat sources, drives worse liver injury and enhanced susceptibility to bacterial infections. | 2020 | Details |
| A06803 | 32739036 | Am J Med Sci | Validation of a Non-Laboratory Based Screening Tool for Predicting Non-Alcoholic Fatty Liver Disease in an Egyptian Setting. | 2020 | Details |
| A06804 | 32738842 | J Assoc Physicians India | Study and Comparison of Metabolic Profile of Lean and Obese Subjects with Non Alcoholic Fatty Liver Disease. | 2020 | Details |
| A06805 | 32738448 | J Hepatol | Reduced Nogo expression inhibits diet-induced metabolic disorders by regulating ChREBP and insulin activity. | 2020 | Details |
| A06806 | 32738398 | Free Radic Biol Med | Generation of sphingosine-1-phosphate by sphingosine kinase 1 protects nonalcoholic fatty liver from ischemia/reperfusion injury through alleviating reactive oxygen species production in hepatocytes. | 2020 | Details |
| A06807 | 32738385 | Alcohol | Moderate alcohol consumption is not associated with subclinical cardiovascular damage but with hepatic fibrosis in non-alcoholic fatty liver disease. | 2020 | Details |
| A06808 | 32738331 | Toxicol Appl Pharmacol | A novel bile acid analog, A17, ameliorated non-alcoholic steatohepatitis in high-fat diet-fed hamsters. | 2020 | Details |
| A06809 | 32738301 | Biochim Biophys Acta Mol Cell Biol Lipids | Palmitoleic acid reduces high fat diet-induced liver inflammation by promoting PPAR-γ-independent M2a polarization of myeloid cells. | 2020 | Details |
| A06810 | 32738185 | Mol Nutr Food Res | The Gut Microbiota and Its Metabolites, Novel Targets for Treating and Preventing Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A06812 | 32738061 | Hepatology | Prenatal Exposure to Perfluoroalkyl Substances Associated With Increased Susceptibility to Liver Injury in Children. | 2020 | Details |
| A06813 | 32737958 | Liver Int | Pulmonary function is associated with fibrosis severity in patients with biopsy-proven nonalcoholic fatty liver disease. | 2020 | Details |
| A06814 | 32737656 | Inflammation | Electroacupuncture Attenuates Liver Inflammation in Nonalcoholic Fatty Liver Disease Rats. | 2020 | Details |
| A06815 | 32736956 | Nutr Metab Cardiovasc Dis | Elevated blood pressure, cardiometabolic risk and target organ damage in youth with overweight and obesity. | 2020 | Details |
| A06816 | 32736892 | Clin Investig Arterioscler | Association between non alcoholic fatty liver disease, metabolic and vascular risk. | 2020 | Details |
| A06817 | 32736293 | Nutr Res | Association between eating speed and newly diagnosed nonalcoholic fatty liver disease among the general population. | 2020 | Details |
| A06818 | 32736139 | J Proteomics | Identification of p115 as a novel ACSL4 interacting protein and its role in regulating ACSL4 degradation. | 2020 | Details |
| A06819 | 32735532 | Endocr Metab Immune Disord Drug Targets | Ferroptotic Cell Death: New Regulatory Mechanisms for Metabolic Diseases. | 2021 | Details |
| A06820 | 32734608 | J Pharm Pharmacol | HWL-088, a new and highly effective FFA1/PPARδ dual agonist, attenuates nonalcoholic steatohepatitis by regulating lipid metabolism, inflammation and fibrosis. | 2020 | Details |
| A06821 | 32734407 | Hepatol Int | Effect of COVID-19 on patients with compensated chronic liver diseases. | 2020 | Details |
| A06822 | 32734012 | Porto Biomed J | An albino mouse model of nonalcoholic fatty liver disease induced using high-fat liquid "Lieber-DeCarli" diet: a preliminary investigation. | 2020 | Details |
| A06823 | 32733940 | Biomed Res Int | An Overview of Lipid Metabolism and Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A06824 | 32733933 | Biomed Res Int | Ginsenoside Rb1 Alleviated High-Fat-Diet-Induced Hepatocytic Apoptosis via Peroxisome Proliferator-Activated Receptor γ. | 2020 | Details |
| A06825 | 32733906 | Front Med (Lausanne) | Selective Thyroid Hormone Receptor-Beta (TRβ) Agonists: New Perspectives for the Treatment of Metabolic and Neurodegenerative Disorders. | 2020 | Details |
| A06826 | 32733807 | Front Oncol | Mechanisms of RNA N6-Methyladenosine in Hepatocellular Carcinoma: From the Perspectives of Etiology. | 2020 | Details |
| A06827 | 32733017 | Sci Rep | Determining the contribution of a high-fructose corn syrup formulation to hepatic glycogen synthesis during ad-libitum feeding in mice. | 2020 | Details |
| A06828 | 32732616 | Transplantation | Association of α 1 Antitrypsin Phenotype and Development of Advanced Liver Disease and Pulmonary Complications Before and After Liver Transplantation. | 2021 | Details |
| A06829 | 32731709 | Wiad Lek | Features of some anthropometric indices and indices of insulin resistance in patients with non-alcoholic steatohepatitis on the background of obesity and osteoarthritis. | 2020 | Details |
| A06830 | 34865380 | Zhonghua Nei Ke Za Zhi | [The investigation and prognosis in patients with non-alcoholic fatty liver disease and coronary vulnerable plaque]. | 2020 | Details |
| A06831 | 32731119 | Cytokine | Osteocalcin and osteoprotegerin levels and their relationship with adipokines and proinflammatory cytokines in children with nonalcoholic fatty liver disease. | 2020 | Details |
| A06832 | 32730863 | Toxicol In Vitro | Fructose-palmitate based high calorie induce steatosis in HepG2 cells via mitochondrial dysfunction: An in vitro approach. | 2020 | Details |
| A06834 | 32730794 | J Hepatol | Update of the simplified criteria for autoimmune hepatitis: Evaluation of the methodology for immunoserological testing. | 2020 | Details |
| A06835 | 32730664 | Liver Int | Prognostic value of multiparametric magnetic resonance imaging, transient elastography and blood-based fibrosis markers in patients with chronic liver disease. | 2020 | Details |
| A06836 | 32730345 | PLoS One | Increased hepatic and circulating chemokine and osteopontin expression occurs early in human NAFLD development. | 2020 | Details |
| A06837 | 32729704 | Minerva Med | Ancient wheats: beneficial effects on insulin resistance. | 2020 | Details |
| A06838 | 32728634 | Clin Exp Hepatol | Left ventricular diastolic dysfunction in liver transplantation: a stronger association with non-alcoholic steatohepatitis. | 2020 | Details |
| A06839 | 32728632 | Clin Exp Hepatol | Glutathione S-transferase T1 and M1 null genotype distribution among non-alcoholic fatty liver disease patients and its association with cytokine and adipokine profiles. | 2020 | Details |
| A06840 | 32728158 | Sci Rep | Fatty acid mimetic PBI-4547 restores metabolic homeostasis via GPR84 in mice with non-alcoholic fatty liver disease. | 2020 | Details |
| A06841 | 32727662 | Gastroenterol Hepatol | COVID-19 and liver disease: An update. | 2020 | Details |
| A06842 | 32727275 | Biodemography Soc Biol | Obesity and metabolic outcomes in a safety-net health system. | 2020 | Details |
| A06843 | 32726654 | Eur J Pharmacol | Neuregulin 4 alleviates hepatic steatosis via activating AMPK/mTOR-mediated autophagy in aged mice fed a high fat diet. | 2020 | Details |
| A06845 | 32725485 | Diabetes Ther | Establishment of a Risk Prediction Model for Non-alcoholic Fatty Liver Disease in Type 2 Diabetes. | 2020 | Details |
| A06846 | 32725250 | Acta Derm Venereol | Hidradenitis Suppurativa is Associated with Non-alcoholic Fatty Liver Disease: A Cross-sectional Study. | 2020 | Details |
| A06847 | 32725157 | J Clin Endocrinol Metab | Pancreatic Steatosis Associates With Impaired Insulin Secretion in Genetically Predisposed Individuals. | 2020 | Details |
| A06848 | 32724826 | J Diabetes Res | A Network-Based Approach to Explore the Mechanism and Bioactive Compounds of Erzhi Pill against Metabolic Dysfunction-Associated Fatty Liver Disease. | 2020 | Details |
| A06849 | 32724678 | Int J Hepatol | Endothelial Dysfunction, a Marker of Atherosclerosis, Is Independent of Metabolic Syndrome in NAFLD Patients. | 2020 | Details |
| A06850 | 32724586 | Food Sci Nutr | Extraction and structural analysis of Angelica sinensis polysaccharide with low molecular weight and its lipid-lowering effect on nonalcoholic fatty liver disease. | 2020 | Details |
| A06851 | 32724031 | Minerva Gastroenterol Dietol | Helicobacter pylori and non-alcoholic fatty liver disease. | 2020 | Details |
| A06852 | 32723931 | Wiad Lek | Arginine/citrulline cycle changes in diet-induced rat model of non-alcoholic fatty liver disease. | 2020 | Details |
| A06853 | 32723353 | BMC Res Notes | Capparis spinosa improves the high fat diet-induced non-alcoholic steatohepatitis in rats: the possible role of FGF21. | 2020 | Details |
| A06854 | 32721044 | FASEB J | Hepatic STAMP2 mediates recombinant FGF21-induced improvement of hepatic iron overload in nonalcoholic fatty liver disease. | 2020 | Details |
| A06855 | 32720691 | Hum Mol Genet | Insights into genetic variants associated with NASH-fibrosis from metabolite profiling. | 2020 | Details |
| A06856 | 32720602 | Curr Vasc Pharmacol | Have We Learnt all from IMPROVE-IT? Part I. Core Results and Subanalyses on the Effects of Ezetimibe Added to Statin Therapy Related to Age, Gender and Selected Chronic Diseases (Kidney Disease, Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease). | 2021 | Details |
| A06857 | 32720262 | Obes Surg | Bariatric Surgery in the Setting of Liver Cirrhosis with Portal Hypertension: the Confection and Particularities of Roux-en-Y Gastric Bypass in a High-Risk Patient. | 2020 | Details |
| A06858 | 32720036 | Purinergic Signal | Design and in vivo activity of A3 adenosine receptor agonist prodrugs. | 2020 | Details |
| A06859 | 32719616 | Front Physiol | The Emerging Role of Hepatocellular eNOS in Non-alcoholic Fatty Liver Disease Development. | 2020 | Details |
| A06860 | 32719241 | Saudi J Gastroenterol | The association between SNPs rs1800591 and rs3816873 of the MTTP gene and nonalcoholic fatty liver disease: A meta-analysis. | 2020 | Details |
| A06861 | 32719069 | J Pharmacol Exp Ther | The GPR40 Full Agonist SCO-267 Improves Liver Parameters in a Mouse Model of Nonalcoholic Fatty Liver Disease without Affecting Glucose or Body Weight. | 2020 | Details |
| A06862 | 32718371 | Br J Nutr | Lactobacillus casei YRL577 ameliorates markers of non-alcoholic fatty liver and alters expression of genes within the intestinal bile acid pathway. | 2020 | Details |
| A06863 | 32718364 | Br J Nutr | Lactobacillus casei YRL577 combined with plant extracts reduce markers of non-alcoholic fatty liver disease in mice. | 2020 | Details |
| A06864 | 32718097 | Int J Mol Sci | Data on Adiponectin from 2010 to 2020: Therapeutic Target and Prognostic Factor for Liver Diseases? | 2020 | Details |
| A06865 | 32717951 | Cells | MicroRNA-221: A Fine Tuner and Potential Biomarker of Chronic Liver Injury. | 2020 | Details |
| A06866 | 32717871 | Int J Mol Sci | Gut Microbiota Metabolites in NAFLD Pathogenesis and Therapeutic Implications. | 2020 | Details |
| A06867 | 32717363 | Ann Hepatol | Dietary consumption and serum pattern of bioactive fatty acids in NAFLD patients. | 2020 | Details |
| A06868 | 32717288 | J Hepatol | Targeting NFATc4 attenuates non-alcoholic steatohepatitis in mice. | 2020 | Details |
| A06869 | 32717228 | Biochem Pharmacol | From fatty hepatocytes to impaired bile flow: Matching model systems for liver biology and disease. | 2020 | Details |
| A06870 | 32717123 | Aliment Pharmacol Ther | Improvement in histological endpoints of MAFLD following a 12-week aerobic exercise intervention. | 2020 | Details |
| A06871 | 32715793 | Expert Rev Gastroenterol Hepatol | Noninvasive diagnostic tools for pediatric NAFLD: where are we now? | 2020 | Details |
| A06872 | 32715667 | J Korean Med Sci | Changes in Characteristics of Patients with Liver Cirrhosis Visiting a Tertiary Hospital over 15 Years: a Retrospective Multi-Center Study in Korea. | 2020 | Details |
| A06873 | 32715385 | Arch Pharm Res | Ganoderic acid A attenuates high-fat-diet-induced liver injury in rats by regulating the lipid oxidation and liver inflammation. | 2020 | Details |
| A06874 | 32715106 | Biochem Biophys Rep | Dantrolene prevents hepatic steatosis by reducing cytoplasmic Ca2+ level and ER stress. | 2020 | Details |
| A06875 | 32714888 | Front Public Health | Risk Prediction for Non-alcoholic Fatty Liver Disease Based on Biochemical and Dietary Variables in a Chinese Han Population. | 2020 | Details |
| A06876 | 32713378 | Br J Nutr | Higher flavonoid intake is associated with a lower progression risk of non-alcoholic fatty liver disease in adults: a prospective study. | 2020 | Details |
| A06877 | 32712601 | Aging (Albany NY) | Decreased autophagy and fuel switching occur in a senescent hepatic cell model system. | 2020 | Details |
| A06878 | 32712221 | Metabolism | The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease. | 2020 | Details |
| A06879 | 32712103 | Gastroenterology | Progression of Fatty Liver Disease in Children Receiving Standard of Care Lifestyle Advice. | 2020 | Details |
| A06880 | 32712045 | Asian J Surg | Sleeve gastrectomy ameliorated high-fat diet (HFD)-induced non-alcoholic fatty liver disease and upregulated the nicotinamide adenine dinucleotide +/ Sirtuin-1 pathway in mice. | 2020 | Details |
| A06881 | 32711755 | J Pediatr | Muscle Mass Is Linked to Liver Disease Severity in Pediatric Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A06882 | 32711187 | Transl Res | The GLP-1R agonist liraglutide limits hepatic lipotoxicity and inflammatory response in mice fed a methionine-choline deficient diet. | 2020 | Details |
| A06883 | 32710938 | Clin Chim Acta | Sumoylation in liver disease. | 2020 | Details |